Tricuspid / Pulmonary valve

This study highlights the TRISCORE's role in assessing risk for patients undergoing TTVI. Despite limitations, TRISCORE effectively identifies high-risk patients, aiding decision-making in a complex landscape of valvular heart disease management.

This study, based on the trial inclusion and exclusion criteria, aimed to compare outcomes in a contemporary “real-world” T-TEER cohort stratified by TRILUMINATE eligibility or ineligibility.

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video, you will:

• appreciate the challenges in patient assessment 
• understand the need for adjunctive treatment targets
• acknowledge challenges in multivalvular disease

1. Disease stages: criteria of futility and optimal response
2. RV...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.

In this video you will learn:

• the theoretical implications of TR reduction for RV performance
• the clinical implications of TR reduction for biventricular performance

Implications of TTVI

Previous episode

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video you will learn about:

• the data supporting prognostic implications of interventional TR reduction
• the prognostic value of hemodynamic factors
• the importance of central venous congestion

1. Mortality and HF Hospitalization: Prognostic Benefit of Intervention...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.

In this video you will learn:

• to recall the unique physiology of right ventricular function
• to understand the implications of RV pressure and volume load using the pressure-volume-loop framework
• to illustrate the...

Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.

Watch this session to get an overview of a new TEER device, follow the step-by-step procedure related to initial experiences with this device for a Japanese patient with degenerative mitral regurgitation, learn about the latest data from RCT and registries, and follow discussions of challenging TEER...

Consult this session if you want to understand T-TEER/TTVR procedure, learn about clinical indication and appropriate patient selection for TEER/TTVR based on TRILUMINATE trial/TRISCEND study, and update your knowledge of current transcatheter technologies for tricuspid regurgitation.

This session of rapid-fire submitted cases focuses on outcome studies after valvular intervention. Learn about clinical impacts of cerebral micro-bleeds in patients undergoing TAVI, explore the long-term outcomes of Venus P valve for dysfunctional right ventricular outflow tract, and more!